<DOC>
	<DOCNO>NCT01720459</DOCNO>
	<brief_summary>The purpose study determine whether micronized trans-resveratrol improve clinical ( excessive hair , menstrual cycle ) , endocrine ( androgen ) metabolic ( lipid , marker systemic inflammation ) woman polycystic ovary syndrome ( PCOS ) .</brief_summary>
	<brief_title>Effects Micronized Trans-resveratrol Treatment Polycystic Ovary Syndrome ( PCOS ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>PCO Androgen Excess Society criterion : hyperandrogenism ( hirsutism ) / hyperandrogenemia ( testosterone &gt; 70ng/dl ) and/or oligomenorrhea ( &lt; 8 spontaneous menses per year ) and/or polycystic ovarian morphology ultrasound Normal prolactin , TSH , 17OH progesterone No evidence androgen produce malignancy , Cushing 's syndrome acromegaly Age 1840 Use oral contraceptive and/or steroid hormone 3 month prior study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>